Gene: CDON
Official Full Name: cell adhesion associated, oncogene regulatedprovided by HGNC
Gene Summary: This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10096 | CDON Knockout cell line (HeLa) | Human | CDON | 1:3~1:6 | Negative | Online Inquiry |
KO10097 | CDON Knockout cell line (HCT 116) | Human | CDON | 1:2~1:4 | Negative | Online Inquiry |
KO10098 | CDON Knockout cell line (HEK293) | Human | CDON | 1:3~1:6 | Negative | Online Inquiry |
KO10099 | CDON Knockout cell line (A549) | Human | CDON | 1:3~1:4 | Negative | Online Inquiry |
CDON Gene Knockout Cell Lines are meticulously engineered cell cultures designed to facilitate the in-depth study of the CDON gene's role in cellular processes and developmental biology. These cell lines are created using advanced CRISPR/Cas9 genome-editing technology, ensuring a precise deletion of the CDON gene, which encodes a key protein involved in the hedgehog signaling pathway. By eliminating this gene, researchers can explore the implications of its absence on cellular differentiation, proliferation, and migration.
The primary function of CDON Gene Knockout Cell Lines lies in their ability to provide a controlled environment for studying alterations in signaling pathways associated with developmental disorders and cancers. These knockouts allow scientists to analyze phenotypic changes, gene expression profiles, and cellular behaviors that may be linked to CDON's regulatory functions, making them invaluable tools in both basic and applied biological research.
The scientific importance of these cell lines extends to their potential applications in understanding congenital malformations, neurological disorders, and tumorigenesis, positioning them as crucial assets in biomedical research. They support high-throughput screening efforts and therapeutic development, thus driving innovation in clinical settings.
Unlike other gene knockout models, our CDON Gene Knockout Cell Lines stand out due to their validated and reproducible knockout efficiency, comprehensive characterization, and user-friendly handling protocols. This ensures that researchers can derive reliable data without concerns of off-target effects commonly associated with less refined methodologies.
The value of CDON Gene Knockout Cell Lines to researchers and clinicians is substantial; they unlock new avenues for investigating disease mechanisms and testing potential drug candidates, ultimately aiming to improve patient outcomes. By bridging the gap between fundamental biology and translational medicine, these cell lines serve as a cornerstone for groundbreaking discoveries.
Backed by our company's extensive expertise in genetic engineering and cell line development, we are committed to delivering high-quality biological products that empower the scientific community in their quest for knowledge and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.